p21 and p53 in ovarian carcinoma

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer

• Publication date

  2001-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(20010815)92:4<781::AID-CNCR1383>3.0.CO;2-PPMID 11550148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

  2000cited by this paper
• p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.

  2000cited by this paper
• p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma.

  2000cited by this paper
• p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.

  1999cited by this paper
• p53 mutations and expression in ovarian cancers: correlation with overall survival.

  1999cited by this paper
• The onset and extent of genomic instability in sporadic colorectal tumor progression.

  1999cited by this paper
• Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.

  1999cited by this paper
• Global cancer statistics

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas

  1999cited by this paper
• p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Quantification of p53 in epithelial ovarian cancer.

  1997cited by this paper
• Prognostic significance of ras/p21 alterations in human ovarian cancer.

  1997cited by this paper
• An abundance of p53 null mutations in ovarian carcinoma.

  1996cited by this paper
• Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

  1996cited by this paper
• Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells

  1994cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

  1994cited by this paper
• p53 gene mutations and protein accumulation in human ovarian cancer.

  1993cited by this paper
• Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.

  1993cited by this paper
• Mutation of p53 gene in hepatocellular carcinoma in Taiwan.

  1992cited by this paper
• Overexpression and mutation of p53 in epithelial ovarian cancer.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper

• Gancao Nurish-Yin Decoction medicated serum inhibits growth and migration of ovarian cancer cells: network pharmacology-based analysis and biological validation

  2022cites this paper
• The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer—Hyperthermia versus Normothermia: A Randomized Controlled Trial

  2021cites this paper
• Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study

  2019cites this paper
• n-Hexane Extract of Mangrove Leaves Effect on p21 and Akt 2 Gene Expressions of WiDr Cells

  2019cites this paper
• Importancia de la temperatura de la quimioterapia intraperitoneal intraoperatoria con paclitaxel en el tratamiento quirúrgico radical de la carcinomatosis peritoneal de origen ovárico. Hipertermia versus normotermia

  2017cites this paper
• Exploiting synthetic lethality in ovarian cancer

  2016cites this paper
• Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma

  2016cites this paper
• Cyclin E is overexpressed by clear cell carcinomas of the endometrium and is a prognostic indicator of survival.

  2015cites this paper
• 14 P 53 Network in Ovarian Cancer

  2014cites this paper
• Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.

  2013cites this paper
• Association of p 21 , p 21 p 27 and p 21 p 53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer

  2013cites this paper
• TP53 mutations in myelodysplastic syndromes with deletion of 5q

  2013cites this paper
• New Hypothesis on Pathogenesis of Ovarian Cancer Lead to Future Tailored Approaches

  2013cites this paper
• P53 Network in Ovarian Cancer

  2012cites this paper
• OverinYüzeyEpitelyal-StromalTümörlerindeTp53Ekspresyonu veKi-67ProliferasyonİndeksiveHistopatolojikPrognostik Parametrelerleİlişkileri

  2011cites this paper
• Tp53 Expression and Ki-67 Proliferation Index in Surface Epithelial-Stromal Tumors of the Ovary and Their Relationship with the Histopathological Prognostic Parameters

  2010influential citation
• VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.

  2010cites this paper
• Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.

  2008cites this paper
• p53 y su papel en el epitelio superficial del ovario. Revisión.

  2008cites this paper
• [P53 and its role in the ovarian surface epithelium. A review].

  2008cites this paper
• Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

  2008cites this paper
• THE ROLE OF C-JUN/AP-1 IN MICROTUBULE INHIBITOR-INDUCED APOPTOSIS

  2008cites this paper
• Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.

  2008cites this paper
• Alteration of cell-cycle regulation in epithelial ovarian cancer

  2007cites this paper
• p21WAF1/CIP1 Is a Common Transcriptional Target of Retinoid Receptors

  2007cites this paper
• Molecular Markers in Epithelial Ovarian Cancer

  2007cites this paper
• The role of cell cycle genes in The diagnosis and Therapy of ovarian cancer

  2007cites this paper
• Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.

  2006cites this paper
• Testing of Functional Integrity of p53 Protein in Primary Breast Cancer by a Rapid Quantitative p53-p21WAF1 Double Assay May Improve the Clinical Value of p53

  2006cites this paper
• Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer

  2006influential citation
• Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma.

  2006cites this paper
• p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas

  2005cites this paper
• Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary.

  2005cites this paper
• The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer

  2005cites this paper
• The Relationship ofMolecularMarkers of p 53 Function and Angiogenesis to Prognosis of Stage IEpithelial Ovarian Cancer

  2005cites this paper
• Cyclin D 1 , p 53 , and p 21 Waf 1 / Cip 1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer

  2004cites this paper
• Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.

  2004cites this paper
• Critical evaluation of p53 as a prognostic marker in ovarian cancer

  2004cites this paper
• Cell Cycle Genes in Ovarian Cancer

  2004cites this paper
• Correlation between responsiveness of neoadjuvant chemotherapy and apoptosis-associated proteins for cervical adenocarcinoma.

  2004cites this paper
• Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma

  2004cites this paper
• Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer

  2004cites this paper
• Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients.

  2004cites this paper
• Nuclear and cytoplasmic c‐myc staining in endometrial carcinoma and their relationship to survival

  2004cites this paper
• Prognostic factors in ovarian cancer: current evidence and future prospects

  2003cites this paper
• A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

  2003cites this paper
• P 21 WAF 1 , P 27 KIP 1 , TP 53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens

  2003cites this paper
• Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy.

  2003cites this paper
• P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

  2003cites this paper
• TUMOR MARKERS IN PHEOCHROMOCYTOMAS

  2003cites this paper
• p21 expression predicts outcome in p53-null ovarian carcinoma.

  2003cites this paper
• P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer

  2002cites this paper
• Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

  2002cites this paper
• P53 and Bcl‐2 as prognostic predictors in epithelial ovarian cancer

  2002cites this paper
• Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.

  2002cites this paper